The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

On September 20, 2012, a marketing authorization valid throughout the European Union (EU) was issued for decitabine for the treatment of adult patients aged 65 years and older with newly diagnosed de novo or secondary acute myeloid leukemia (AML) who are not candidates for standard induction chemoth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Nieto, Maria, Demolis, Pierre, Béhanzin, Eliane, Moreau, Alexandre, Hudson, Ian, Flores, Beatriz, Stemplewski, Henry, Salmonson, Tomas, Gisselbrecht, Christian, Bowen, David, Pignatti, Francesco
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2016
Schlagworte:
Regulatory Issues: EMA
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4912358/
https://ncbi.nlm.nih.gov/pubmed/27091416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0298
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge